Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More | Frank Vinluan | 04/24/20 | National |
Bio Roundup: Ex-Kiters Say Allo, NASH Cash & Data, Alkermes No & More | Alex Lash | 04/06/18 | National |
Virta Health Hauls in $45M to Expand “Diabetes-Reversing” Software | Frank Vinluan | 04/04/18 | San Francisco |
Biotech Roundup: Obamacare Lite, DePinho Out, Dunsire In & More | Ben Fidler | 03/10/17 | National |
Backed by $37M, Virta Tries Tech Approach to “Reverse” Diabetes | Frank Vinluan | 03/08/17 | San Francisco |